Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

Autor: Kho, P-F, Amant, F, Annibali, D, Ashton, K, Attia, J, Auer, PL, Beckmann, MW, Black, A, Brinton, L, Buchanan, DD, Chen, C, Chen, MM, Cheng, THT, Cook, LS, Crous-Bous, M, Czene, K, De Vivo, I, Dennis, J, Dörk, T, Dowdy, SC, Dunning, AM, Dürst, M, Easton, DF, Ekici, AB, Fasching, PA, Fridley, BL, Friedenreich, CM, García-Closas, M, Gaudet, MM, Giles, GG, Goode, EL, Gorman, M, Haiman, CA, Hall, P, Hankison, SE, Hein, A, Hillemanns, P, Hodgson, S, Hoivik, EA, Holliday, EG, Hunter, DJ, Jones, A, Kraft, P, Krakstad, C, Lambrechts, D, Le Marchand, L, Liang, X, Lindblom, A, Lissowska, J, Long, J, Lu, L, Magliocco, AM, Martin, L, McEvoy, M, Milne, RL, Mints, M, Nassir, R, Otton, G, Palles, C, Pooler, L, Proietto, T, Rebbeck, TR, Renner, SP, Risch, HA, Rübner, M, Runnebaum, I, Sacerdote, C, Sarto, GE, Schumacher, F, Scott, RJ, Setiawan, VW, Shah, M, Sheng, X, Shu, X-O, Southey, MC, Tham, E, Tomlinson, I, Trovik, J, Turman, C, Tyrer, JP, Van Den Berg, D, Wang, Z, Wentzensen, N, Xia, L, Xiang, Y-B, Yang, HP, Yu, H, Zheng, W, Webb, PM, Thompson, DJ, Spurdle, AB, Glubb, DM, O'Mara, TA

Blood lipids have been associated with the development of a range of cancers, including breast, lung and colorectal cancer. For endometrial cancer, observational studies have reported inconsistent associations between blood lipids and cancer risk. To

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6c0cf6252663c976386ad57141ccbec8
https://openaccess.sgul.ac.uk/id/eprint/112317/1/Kho_ECAC_lipid_MR_manuscript_2020-07-07.doc

Extending the phenotype of Shashi-Pena syndrome: a case report and review of literature.

Autor: Ho SKL; Department of Health, Clinical Genetic Service., Cheng SSW; Clinical Genetics Service Unit, Hong Kong Children's Hospital., Cheng THT; Department of Pathology, Hong Kong Children's Hospital, HKSAR, Hong Kong., Leung LT; Department of Health, Clinical Genetic Service., Lam EKY; Department of Pathology, Hong Kong Children's Hospital, HKSAR, Hong Kong., Mok MTS; Department of Health, Clinical Genetic Service., Lo IFM; Department of Health, Clinical Genetic Service., Luk HM; Clinical Genetics Service Unit, Hong Kong Children's Hospital.

Publikováno v: Clinical dysmorphology [Clin Dysmorphol] 2023 Jul 01; Vol. 32 (3), pp. 139-146. Date of Electronic Publication: 2023 May 12.

Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.

Autor: Kho PF; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Biomedical Science, Queensland University of Technology, Brisbane, Queensland, Australia., Amant F; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium., Annibali D; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium., Ashton K; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.; Centre for Information Based Medicine, University of Newcastle, Callaghan, New South Wales, Australia.; Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia., Attia J; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Auer PL; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA., Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Black A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Buchanan DD; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia., Chanock SJ; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Chen C; Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Chen MM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Cheng THT; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK., Cook LS; University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada., Crous-Bous M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., De Vivo I; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany., Dowdy SC; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Mayo Clinic, Rochester, Minnesota, USA., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Dürst M; Department of Gynaecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, USA., Fridley BL; Department of Biostatistics, Kansas University Medical Center, Kansas City, Kansas, USA., Friedenreich CM; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada., García-Closas M; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gaudet MM; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia, USA., Giles GG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Goode EL; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA., Gorman M; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK., Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden., Hankinson SE; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA., Hein A; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Hillemanns P; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany., Hodgson S; Department of Clinical Genetics, St George's, University of London, London, UK., Hoivik EA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway., Holliday EG; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Hunter DJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Jones A; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK., Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Krakstad C; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway., Lambrechts D; VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium., Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Liang X; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Cancer Center, Oncology Institute, Warsaw, Poland., Long J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Lu L; Chronic Disease Epidemiology, Yale School of Medicine, New Haven, Connecticut, USA., Magliocco AM; Department of Anatomic Pathology, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA., Martin L; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., McEvoy M; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Milne RL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Mints M; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Nassir R; Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, California, USA., Otton G; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Palles C; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK., Pooler L; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Proietto T; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Rebbeck TR; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Renner SP; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Risch HA; Chronic Disease Epidemiology, Yale School of Medicine, New Haven, Connecticut, USA., Rübner M; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Runnebaum I; Department of Gynaecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany., Sacerdote C; Center for Cancer Prevention (CPO-Peimonte), Turin, Italy.; Human Genetics Foundation (HuGeF), Turin, Italy., Sarto GE; Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA., Schumacher F; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA., Scott RJ; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.; Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia.; Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia., Setiawan VW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Sheng X; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Southey MC; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Tham E; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Trovik J; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway., Turman C; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Tyrer JP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Van Den Berg D; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Wang Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Xia L; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Xiang YB; State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Yang HP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Yu H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Webb PM; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Thompson DJ; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Glubb DM; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., O'Mara TA; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Publikováno v: International journal of cancer [Int J Cancer] 2021 Jan 15; Vol. 148 (2), pp. 307-319. Date of Electronic Publication: 2020 Aug 07.

A Targeted Gene Panel That Covers Coding, Non-coding and Short Tandem Repeat Regions Improves the Diagnosis of Patients With Neurodegenerative Diseases.

Autor: Yu AC; Codex Genetics Limited, Shatin, Hong Kong.; School of Life Sciences, The Chinese University of Hong Kong, Shatin, China., Yim AK; Codex Genetics Limited, Shatin, Hong Kong.; Computational and System Biology Program, Washington University School of Medicine, Saint Louis, MO, United States., Chan AY; Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, China., Yuen LYP; Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, China., Au WC; Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, China.; Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Shatin, China., Cheng THT; Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, China., Lin X; School of Life Sciences, The Chinese University of Hong Kong, Shatin, China., Li JW; Codex Genetics Limited, Shatin, Hong Kong., Chan LWL; Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong., Mok VCT; Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, China.; Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Shatin, China., Chan TF; Codex Genetics Limited, Shatin, Hong Kong.; School of Life Sciences, The Chinese University of Hong Kong, Shatin, China.; Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Shatin, China., Chan HYE; Codex Genetics Limited, Shatin, Hong Kong.; School of Life Sciences, The Chinese University of Hong Kong, Shatin, China.; Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Shatin, China.

Publikováno v: Frontiers in neuroscience [Front Neurosci] 2019 Dec 11; Vol. 13, pp. 1324. Date of Electronic Publication: 2019 Dec 11 (Print Publication: 2019).

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.

Autor: Sun K; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Jiang P; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Cheng SH; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Cheng THT; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Wong J; Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Wong VWS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Ng SSM; Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Ma BBY; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Leung TY; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Chan SL; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Mok TSK; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Lai PBS; Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Chan HLY; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Sun H; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Chan KCA; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Chiu RWK; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China., Lo YMD; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.

Publikováno v: Genome research [Genome Res] 2019 Mar; Vol. 29 (3), pp. 418-427.